The standards of reporting trials in pets (PetSORT): Explanation and elaboration

被引:5
|
作者
Sargeant, Jan M. [1 ]
Ruple, Audrey [2 ]
Selmic, Laura E. [3 ]
O'Connor, Annette M. [4 ]
PetSORT Consensus Grp
机构
[1] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada
[2] Virginia Tech, Virginia Maryland Coll Vet Med, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA
[3] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH USA
[4] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI USA
关键词
animal reporting guidelines; animal health; randomized trials; small animal clinical trials; companion animals; RANDOMIZED CONTROLLED-TRIALS; MITRAL-VALVE DISEASE; CORE OUTCOME SET; CLINICAL-TRIALS; CONSORT STATEMENT; SAMPLE-SIZE; SYSTEMATIC REVIEWS; EXTERNAL VALIDITY; ORAL TRANSMUCOSAL; COCHRANE REVIEWS;
D O I
10.3389/fvets.2023.1137781
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Well-designed randomized controlled trials (RCTs) provide the best evidence of the primary research designs for evaluating the effectiveness of interventions. However, if RCTs are incompletely reported, the methodological rigor with which they were conducted cannot be reliably evaluated and it may not be possible to replicate the intervention. Missing information also may limit the reader's ability to evaluate the external validity of a trial. Reporting guidelines are available for clinical trials in human healthcare (CONSORT), livestock populations (REFLECT), and preclinical experimental research involving animals (ARRIVE 2.0). The PetSORT guidelines complement these existing guidelines, providing recommendations for reporting controlled trials in pet dogs and cats. The rationale and scientific background are explained for each of the 25 items in the PetSORT reporting recommendations checklist, with examples from well-reported trials.
引用
收藏
页数:24
相关论文
共 50 条
  • [41] CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration
    Li, Jiang
    Hu, Jia-yuan
    Zhai, Jing-bo
    Niu, Jun-qiang
    Kwong, Joey S. W.
    Ge, Long
    Li, Bo
    Wang, Qi
    Wang, Xiao-qin
    Wei, Dang
    Tian, Jin-hui
    Ma, Bin
    Yang, Ke-hu
    Dai, Min
    Tian, Gui-hua
    Shan, Hong-cai
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 46 : 180 - 188
  • [42] STANDARDS FOR REPORTING CLINICAL-TRIALS
    BOISSEL, JP
    CLINICAL TRIALS AND META-ANALYSIS, 1993, 28 (4-5) : 195 - 197
  • [43] Standards for Reporting PET Clinical Trials
    Eary, Janet F.
    Krohn, Kenneth A.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (09) : 1516 - 1517
  • [44] STANDARDS FOR REPORTING CLINICAL-TRIALS
    BOISSEL, JP
    CLINICAL TRIALS AND META-ANALYSIS, 1993, 28 (06) : 305 - 307
  • [45] STANDARDS FOR REPORTING CLINICAL-TRIALS
    BOISSEL, JP
    CLINICAL TRIALS AND META-ANALYSIS, 1994, 29 (01) : R5 - R7
  • [46] Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
    Janssens, A. Cecile J. W.
    Ioannidis, John P. A.
    Bedrosian, Sara
    Boffetta, Paolo
    Dolan, Siobhan M.
    Dowling, Nicole
    Fortier, Isabel
    Freedman, Andrew N.
    Grimshaw, Jeremy M.
    Gulcher, Jeffrey
    Gwinn, Marta
    Hlatky, Mark A.
    Janes, Holly
    Kraft, Peter
    Melillo, Stephanie
    O'Donnell, Christopher J.
    Pencina, Michael J.
    Ransohoff, David
    Schully, Sheri D.
    Seminara, Daniela
    Winn, Deborah M.
    Wright, Caroline F.
    van Duijn, Cornelia M.
    Little, Julian
    Khoury, Muin J.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2011, 26 (04) : 313 - 337
  • [47] Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
    Janssens, A. Cecile J. W.
    Ioannidis, John P. A.
    Bedrosian, Sara
    Boffetta, Paolo
    Dolan, Siobhan M.
    Dowling, Nicole
    Fortier, Isabel
    Freedman, Andrew N.
    Grimshaw, Jeremy M.
    Gulcher, Jeffrey
    Gwinn, Marta
    Hlatky, Mark A.
    Janes, Holly
    Kraft, Peter
    Melillo, Stephanie
    O'Donnell, Christopher J.
    Pencina, Michael J.
    Ransohoff, David
    Schully, Sheri D.
    Seminara, Daniela
    Winn, Deborah M.
    Wright, Caroline F.
    van Duijn, Cornelia M.
    Little, Julian
    Khoury, Muin J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (09) : 1010 - 1035
  • [48] STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
    Cohen, Jeremie F.
    Korevaar, Daniel A.
    Altman, Douglas G.
    Bruns, David E.
    Gatsonis, Constantine A.
    Hooft, Lotty
    Irwig, Les
    Levine, Deborah
    Reitsma, Johannes B.
    de Vet, Henrica C. W.
    Bossuyt, Patrick M. M.
    BMJ OPEN, 2016, 6 (11):
  • [49] Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
    Douglas G Altman
    Lisa M McShane
    Willi Sauerbrei
    Sheila E Taube
    BMC Medicine, 10
  • [50] SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Gotzsche, Peter C.
    Altman, Douglas G.
    Mann, Howard
    Berlin, Jesse A.
    Dickersin, Kay
    Hrobjartsson, Asbjorn
    Schulz, Kenneth F.
    Parulekar, Wendy R.
    Krleza-Jeric, Karmela
    Laupacis, Andreas
    Moher, David
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346